Trials / Recruiting
RecruitingNCT06266104
Image Enhanced Endoscopy IBD
Image Enhanced Endoscopy Technology to Improve the Detection of Colorectal Dysplasia in Patients With Inflammatory Bowel Disease
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 270 (estimated)
- Sponsor
- Royal Perth Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Dye- spray chromoendoscopy remains the recommended gold standard approach for IBD dysplasia surveillance colonoscopy however recently published European and American guidelines recommend either dye-spray or virtual chromoendoscopy can be used for surveillance. The newer Imaged Enhanced Endoscopy technologies TXI and LCI have not formally been evaluated in IBD surveillance in a randomised controlled trial setting. These modes can easily be applied during colonoscopy and if demonstrated to be effective may save time and eliminate the need for dye-spray chromoendoscopy in the future.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Image Enhanced Endoscopy Filters | Patients that undergoing surveillance and consent to be involved in the study will be randomised to undergo surveillance with LCI, TXI or dye-spray chromoendoscopy (methylene blue). |
Timeline
- Start date
- 2024-04-03
- Primary completion
- 2025-12-31
- Completion
- 2026-03-01
- First posted
- 2024-02-20
- Last updated
- 2024-04-12
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT06266104. Inclusion in this directory is not an endorsement.